MYCN and neuroblastoma: In this study, we demonstrated that KLHL37 competitively interacted with N-Myc and released N-Myc from E3-mediated proteasomal degradation, leading to enhanced stabilization and aberrant activation of N-Myc, ultimately contributing to the malignant progression of neuroblastoma.